[Without short acting insulin analogs. Is therapy quality really maintained? (interview by Dirk Einecke)].
Lüddeke
Hans J
HJ
D017046:Cost Savings / Q000191:economics; D003920:Diabetes Mellitus / Q000188:drug therapy* / Q000191:economics*; D016527:Drug Costs / Q000706:statistics & numerical data*; D005858:Germany; D006801:Humans; D007328:Insulin / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000191:economics*; D049528:Insulin, Long-Acting / Q000191:economics* / Q000627:therapeutic use*; D009313:National Health Programs / Q000191:economics*; D011785:Quality Assurance, Health Care / Q000191:economics*
D007328:Insulin; D049528:Insulin, Long-Acting; C484564:insulin, long-acting, human